5 December 2016 - When the cancer in Karen Cowley's breast spread to her spine and brain, and her current drugs weren't working any more, she decided she wasn't ready to die.

She petitioned the health minister to get her hands on a revolutionary tumour-stopping drug - one that was approved in America, but not Australia.

Her efforts were successful. But she says it costs her $15,000 for only three doses of Kadcyla, an "armed antibody" drug owned by pharmaceutical giant Roche.

She now hopes a new startup will mean no one else has to go through that battle with the federal government to buy what they need.

Read Brisbane Times article